Keryx Biopharmaceuticals, Inc (KERX) Covered Calls

Keryx Biopharmaceuticals, Inc covered calls Keryx Biopharmaceuticals, Inc. is a biopharmaceutical Company, focusing on the acquisition, development & commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease & cancer.

There are no covered calls available for Keryx Biopharmaceuticals, Inc.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.